CD8A and neoplasm: It has also been reported that CD8-positive T cells in the tumor nest exhibit high expression of PD-1 after treatment with PLX3397 [21], suggesting that tumor immunity had been activated mainly in the T cell lineage by the combined use of anti-PD-1 antibody through a similar mechanism in the present study.